BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32101126)

  • 21. Prediction of protein-protein interaction sites from weakly homologous template structures using meta-threading and machine learning.
    Maheshwari S; Brylinski M
    J Mol Recognit; 2015 Jan; 28(1):35-48. PubMed ID: 26268369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding Affinity via Docking: Fact and Fiction.
    Pantsar T; Poso A
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30061498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists.
    Duan X; Zhang X; Xu B; Wang F; Lei M
    Chem Biol Drug Des; 2016 Jul; 88(1):142-54. PubMed ID: 26851125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational drug design targeting protein-protein interactions.
    Bienstock RJ
    Curr Pharm Des; 2012; 18(9):1240-54. PubMed ID: 22316151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction.
    Sillerud LO; Larson RS
    Curr Protein Pept Sci; 2005 Apr; 6(2):151-69. PubMed ID: 15853652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boosted neural networks scoring functions for accurate ligand docking and ranking.
    Ashtawy HM; Mahapatra NR
    J Bioinform Comput Biol; 2018 Apr; 16(2):1850004. PubMed ID: 29495922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hot-spot analysis for drug discovery targeting protein-protein interactions.
    Rosell M; Fernández-Recio J
    Expert Opin Drug Discov; 2018 Apr; 13(4):327-338. PubMed ID: 29376444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design.
    Sotriffer C; Klebe G
    Farmaco; 2002 Mar; 57(3):243-51. PubMed ID: 11989803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2.
    Athanasiou C; Vasilakaki S; Dellis D; Cournia Z
    J Comput Aided Mol Des; 2018 Jan; 32(1):21-44. PubMed ID: 29119352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of protein interactions: co-crystalized protein-protein interfaces are nearly as good as holo proteins in rigid-body ligand docking.
    Belkin S; Kundrotas PJ; Vakser IA
    J Comput Aided Mol Des; 2018 Jul; 32(7):769-779. PubMed ID: 30003468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The scoring bias in reverse docking and the score normalization strategy to improve success rate of target fishing.
    Luo Q; Zhao L; Hu J; Jin H; Liu Z; Zhang L
    PLoS One; 2017; 12(2):e0171433. PubMed ID: 28196116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modern drug design: the implication of using artificial neuronal networks and multiple molecular dynamic simulations.
    Yakovenko O; Jones SJM
    J Comput Aided Mol Des; 2018 Jan; 32(1):299-311. PubMed ID: 29134430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
    Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
    J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of Computational Approaches for Prediction of DNA-Binding Residues on Protein Surfaces.
    Xiong Y; Zhu X; Dai H; Wei DQ
    Methods Mol Biol; 2018; 1754():223-234. PubMed ID: 29536446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicted binding site information improves model ranking in protein docking using experimental and computer-generated target structures.
    Maheshwari S; Brylinski M
    BMC Struct Biol; 2015 Nov; 15():23. PubMed ID: 26597230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distilling the essential features of a protein surface for improving protein-ligand docking, scoring, and virtual screening.
    Zavodszky MI; Sanschagrin PC; Korde RS; Kuhn LA
    J Comput Aided Mol Des; 2002 Dec; 16(12):883-902. PubMed ID: 12825621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing.
    Ozdemir ES; Halakou F; Nussinov R; Gursoy A; Keskin O
    Methods Mol Biol; 2019; 1903():1-21. PubMed ID: 30547433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addressing recent docking challenges: A hybrid strategy to integrate template-based and free protein-protein docking.
    Yan Y; Wen Z; Wang X; Huang SY
    Proteins; 2017 Mar; 85(3):497-512. PubMed ID: 28026062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.